Variation of bone acquisition during growth hormone treatment in children can be explained by proteomic biomarkers, bone formation markers, body composition and nutritional factors
Growth hormone (GH) regulates both longitudinal growth and bone acquisition in children, and has profound metabolic effects. The aim was to investigate the association between proteomic biomarkers, body fat, nutrition and bone formation markers, and longitudinal growth in response to GH during the first year of treatment. The degree to which changes in these factors could explain variations in GH-dependent longitudinal growth and bone mineralization was also assessed.
Source: Bone - Category: Orthopaedics Authors: Diana Swolin-Eide, Bj örn Andersson, Gunnel Hellgren, Per Magnusson, Kerstin Albertsson-Wikland Tags: Full Length Article Source Type: research